" class="no-js "lang="en-US"> EVERSANA - Medtech Alert
Friday, January 17, 2025

Breaking News

Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program Captivate Bio and EverCell Bio partner on Human Cell Modeling Services for Cell and Gene Therapy Markets Applied StemCell Partners with CIRM to Provide Clinical-Grade iPSCs and Access to Its Proprietary Gene Editing Technologies Alentis Therapeutics Receives IND Clearance from FDA for ALE.C04 for the Treatment of CLDN1+ Tumors
EVERSANA | Pharmtech Focus

EVERSANA

About EVERSANA

EVERSANA

EVERSANA™ combines the leading global life science services into an integrated and intelligent commercialization platform. With services rooted in the patient experience and spanning global pricing, market access, marketing, patient support, channel distribution, and consulting, we create value for patients, prescribers and payers at all stages of the product lifecycle.

To learn more about our work to help clients – ranging from innovative start-ups to established pharmaceutical companies – advance life science services for a healthier world, visit eversana.com.

Related Story

News

 EVERSANA® Announces Partnership with ChemoMouthpiece, LLC to Support U.S. Launch & Commercialization of Medical Device to Help Cancer Patients Manage and Treat Oral Mucositis | MTA

EVERSANA® Announces Partnership with ChemoMouthpiece, LLC to Support U.S. Launch & Commercialization of Medical Device to Help Cancer Patients Manage and Treat Oral Mucositis

March 24 2023

EVERSANA, a leading provider of commercialization services to the life science industry, today announced a […]

News

 Xspray Pharma Partners with EVERSANA for the Treatment of Chronic Myeloid Leukemia (CML) and Acute Lymphatic Leukemia (ALL) | MTA

Xspray Pharma Partners with EVERSANA for the Treatment of Chronic Myeloid Leukemia (CML) and Acute Lymphatic Leukemia (ALL)

February 23 2023

Xspray Pharma AB has signed an agreement with EVERSANA to support the U.S. launch and commercialization of […]

Diseases

 Nemaura and EVERSANA sign preliminary agreement for large-scale launch of Nemaura’s Diabetes Management Program in the U.S. | Pharmtech Focus|Nemaura and EverEVERSANA Sign Preliminary Agreement for Large-scale Launch of Nemaura’s Diabetes Management Program in the U.S. | Pharmtech Focus

Nemaura and EVERSANA sign preliminary agreement for large-scale launch of Nemaura’s Diabetes Management Program in the U.S.

September 28 2022

Nemaura Medical, Inc.(NASDAQ: NMRD)(“Nemaura” or the “Company”), a medical technology company focused on developing and […]

News

 EVERSANA Unveils Global Price and Market Access Solution NAVLIN by EVERSANA | Pharmtech Focus

EVERSANA Unveils Global Price and Market Access Solution NAVLIN by EVERSANA

March 18 2022

EVERSANA™, the pioneer of next generation commercial services to the global life sciences industry, today […]

Industry News

 EVERSANA Acquires Protean; Strengthens Operational Strategy and Excellence in Market Access

EVERSANA Acquires Protean; Strengthens Operational Strategy and Excellence in Market Access, Channel and Patient Services

October 18 2021

EVERSANA™, the pioneer of next-generation commercial services to the global life sciences industry, today announced […]

News

 EVERSANA ™ Expands Medical Information and Integrated Compliance Services Across Europe | Pharmtech Focus

EVERSANA ™ Expands Medical Information and Integrated Compliance Services Across Europe

June 21 2021

EVERSANA ™, the pioneer of next generation commercial services to the global life sciences industry, today […]

Cardiovascular

 GENinCode Announces Major US Commercialisation Partnership with EVERSANA | Pharmtech Focus

GENinCode Announces Major US Commercialisation Partnership with EVERSANA

June 14 2021

GENinCode UK Limited, the cardiovascular disease company focused on predictive genetics for the prevention of […]